Vodnjov Nina, Cerar Andraž, Maver Aleš, Peterlin Borut, Writzl Karin
Clinical Institute of Genomic Medicine, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Biotechnical Faculty, University of Ljubljana, Ljubljana, Slovenia.
Orphanet J Rare Dis. 2025 Feb 28;20(1):92. doi: 10.1186/s13023-025-03613-7.
Titin truncating variants (TTNtv-s) are the most common genetic cause of dilated cardiomyopathy (DCM). Only rare TTNtv-s in the constitutively expressed exons of the A-band of the protein titin are associated with DCM according to the guidelines, however, studies in large cohorts of patients with DCM suggest that the region where TTNtv-s are associated with DCM is wider, extending at least into the I-band. The aim of this study was to describe the molecular pathology of TTNtv-s in Slovenian patients with cardiomyopathy and to clinically characterise the most recurrent TTNtv.
We collected all TTNtv-s identified in patients with cardiomyopathy using next-generation sequencing genetic testing between 2010 and July 2024, resulting in 42 unique variants identified in 54 patients. The TTN:c.12478del variant, affecting not the A-band but the proximal I-band, specifically the cardiac-specific N2Bus region, was found to be the most recurrent variant, present in seven (11.6%) probands with DCM. Genetic characterisation revealed a probable founder origin of the variant. Clinical characterisation of these probands revealed a phenotype consistent with DCM and severely reduced left ventricular ejection fraction in all probands. Three (43%) of the probands had atrial fibrillation and/or non-sustained ventricular tachycardia. Based on literature reports and evidence supporting the pathogenicity of the TTN:c.12478del variant affecting the proximal I-band, we classified all rare TTNtv-s in constitutively expressed exons of the I-band as (likely) pathogenic. Therefore, 33 (78.6%) TTNtv-s were classified as (likely) pathogenic (13 in the I-band, affecting 19 probands and 20 in the A-band affecting 25 probands), meaning that TTNtv-s were identified in 44 genotype-positive Slovenian probands with DCM, explaining 73.3% of the molecular pathology of DCM.
We report an almost threefold higher diagnostic yield of TTNtv-s in probands with DCM compared to previously reported findings in cohorts of patients with DCM from other populations. We also highlight the need for screening for rare TTNtv-s in the constitutively expressed exons of the I-band and for TTN:c.12478del in patients with DCM in this geographical region.
肌联蛋白截短变异体(TTNtv-s)是扩张型心肌病(DCM)最常见的遗传病因。根据指南,仅肌联蛋白A带组成型表达外显子中的罕见TTNtv-s与DCM相关,然而,对大量DCM患者队列的研究表明,TTNtv-s与DCM相关的区域更广泛,至少延伸至I带。本研究的目的是描述斯洛文尼亚心肌病患者中TTNtv-s的分子病理学,并对最常见的TTNtv进行临床特征描述。
我们收集了2010年至2024年7月期间通过下一代测序基因检测在心肌病患者中鉴定出的所有TTNtv-s,在54例患者中鉴定出42种独特变异体。发现TTN:c.12478del变异体不影响A带,而是影响近端I带,特别是心脏特异性N2Bus区域,是最常见的变异体,在7例(11.6%)DCM先证者中出现。基因特征分析揭示了该变异体可能的奠基者起源。对这些先证者的临床特征描述显示,其表型与DCM一致,所有先证者的左心室射血分数严重降低。3例(43%)先证者患有心房颤动和/或非持续性室性心动过速。基于文献报道和支持影响近端I带的TTN:c.12478del变异体致病性的证据,我们将I带组成型表达外显子中的所有罕见TTNtv-s分类为(可能)致病。因此,33种(78.6%)TTNtv-s被分类为(可能)致病(I带中有13种,影响19例先证者;A带中有20种,影响25例先证者),这意味着在44例基因型阳性的斯洛文尼亚DCM先证者中鉴定出了TTNtv-s,解释了DCM分子病理学的73.3%。
我们报告,与先前报道的其他人群DCM患者队列的研究结果相比,DCM先证者中TTNtv-s的诊断率几乎高出两倍。我们还强调了在该地理区域对DCM患者I带组成型表达外显子中的罕见TTNtv-s以及TTN:c.12478del进行筛查的必要性。